Biolife Solutions (BLFS) Cash & Current Investments (2010 - 2026)

Biolife Solutions (BLFS) has reported Cash & Current Investments for 17 consecutive years, with $81.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments fell 8.56% year-over-year to $81.0 million; the TTM figure through Mar 2026 stood at $81.0 million (down 8.56% YoY), while the FY2025 annual figure was $88.9 million, down 11.72% from the prior year.
• Cash & Current Investments eased to $81.0 million in Q1 2026 per BLFS's latest filing, from $88.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $100.7 million in Q4 2024 and bottomed at $19.5 million in Q4 2022.
• Historically, Cash & Current Investments has averaged $57.9 million across 5 years, with a median of $54.9 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Current Investments sank 72.13% — and 2025, when it jumped 270.9%.
• Biolife Solutions' Cash & Current Investments stood at $19.5 million in 2022, then jumped by 126.9% to $44.2 million in 2023, then jumped by 127.99% to $100.7 million in 2024, then retreated by 11.72% to $88.9 million in 2025, then declined by 8.92% to $81.0 million in 2026.
• Business Quant data shows BLFS's Cash & Current Investments at $81.0 million in Q1 2026, $88.9 million in Q4 2025, and $79.0 million in Q3 2025.